Allurion Technologies (ALUR) Cash & Current Investments (2022 - 2026)

Allurion Technologies (ALUR) posted Cash & Current Investments of $5.1 million for Q1 2026, down 6.58% on a QoQ basis from $5.4 million in Q4 2025, and down 75.23% year-over-year from $20.4 million in Q1 2025.

Allurion Technologies (ALUR) Cash & Current Investments (2022 - 2026) Analysis & Trends

Allurion Technologies' Cash & Current Investments history runs 5 years deep, the most recent figure standing at $5.1 million for Q1 2026.

  • Quarterly Cash & Current Investments fell 75.23% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 75.23% YoY) and the FY2025 annual result came in at $5.4 million, down 64.81% from the prior year.
  • Cash & Current Investments was $5.1 million for Q1 2026 at Allurion Technologies, down from $5.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $79.9 million in Q3 2023 and bottomed at $4.7 million in Q2 2023.
  • A 5-year average of $21.0 million and a median of $15.4 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments soared 394.95% — and 2025, when it slumped 78.59%.
  • Allurion Technologies' Cash & Current Investments stood at $7.7 million in 2022, then surged by 394.95% to $38.0 million in 2023, then slumped by 59.57% to $15.4 million in 2024, then tumbled by 64.81% to $5.4 million in 2025, then declined by 6.58% to $5.1 million in 2026.
  • Business Quant data shows ALUR's Cash & Current Investments at $5.1 million in Q1 2026, $5.4 million in Q4 2025, and $6.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Allurion Technologies 74.67 Mn 69.62 Mn 1.23 Mn 5.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.06 Mn
Dec 31, 2025 5.41 Mn
Sep 30, 2025 6.14 Mn
Jun 30, 2025 12.72 Mn
Mar 31, 2025 20.41 Mn
Dec 31, 2024 15.38 Mn
Sep 30, 2024 28.65 Mn
Jun 30, 2024 19.26 Mn
Mar 31, 2024 29.68 Mn
Dec 31, 2023 38.04 Mn
Sep 30, 2023 79.87 Mn
Jun 30, 2023 4.74 Mn
Dec 31, 2022 7.69 Mn